NCCN VERSION 2 2015

NCCN Guidelines Version 2.2015 Breast Cancer

NCCN Guidelines Index Breast Cancer Table of Contents Discussion

2006;47:1202-1208. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16818956 .

Breast Cancer 2004;5:317-319. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15507181 . 556. Mir O, Berveiller P, Ropert S, et al. Emerging therapeutic options for breast cancer chemotherapy during pregnancy. Ann Oncol 2008;19:607-613. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17921242 . 557. Bader AA, Schlembach D, Tamussino KF, et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007;8:79-81. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17196514 . 558. Fanale MA, Uyei AR, Theriault RL, et al. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy. Clin 559. Pant S, Landon MB, Blumenfeld M, et al. Treatment of breast cancer with trastuzumab during pregnancy. J Clin Oncol 2008;26:1567- 1569. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18349415 . 560. Sekar R, Stone PR. Trastuzumab use for metastatic breast cancer in pregnancy. Obstet Gynecol 2007;110:507-510. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17666645 . 561. Shrim A, Garcia-Bournissen F, Maxwell C, et al. Favorable pregnancy outcome following Trastuzumab (Herceptin) use during pregnancy--Case report and updated literature review. Reprod Toxicol 2007;23:611-613. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17399946 . 562. Waterston AM, Graham J. Effect of Adjuvant Trastuzumab on Pregnancy. J Clin Oncol 2006;24:321-322. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16401684 . 563. Watson WJ. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnios. Obstet Gynecol Breast Cancer 2005;6:354-356. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16277887 .

548. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004;15:146-150. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14679135 . 549. Johnson PH, Gwyn K, Gordon N, et al. The treatment of pregnant women with breast cancer and the outcomes of the children exposed to chemotherapy in utero [abstract]. J Clin Oncol 2005;23(Suppl 16):Abstract 540. Available at: http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/540 . 550. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337-346. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2678485 . 551. Ebert U, Loffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997;74:207-220. Available at: http://www.ncbi.nlm.nih.gov/pubmed/9336023 . 552. Hahn KME, Johnson PH, Gordon N, et al. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 2006;107:1219-1226. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16894524 . 553. Gainford MC, Clemons M. Breast cancer in pregnancy: are taxanes safe? Clinical Oncol (R Coll Radiol) 2006;18:159. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16523825 . 554. Garcia-Manero M, Royo MP, Espinos J, et al. Pregnancy associated breast cancer. Eur J Surg Oncol 2009;35:215-218. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18550321 . 555. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-107